EP3866981A4 - Procédés de génération de plates-formes d'administration thérapeutique - Google Patents

Procédés de génération de plates-formes d'administration thérapeutique Download PDF

Info

Publication number
EP3866981A4
EP3866981A4 EP19875362.6A EP19875362A EP3866981A4 EP 3866981 A4 EP3866981 A4 EP 3866981A4 EP 19875362 A EP19875362 A EP 19875362A EP 3866981 A4 EP3866981 A4 EP 3866981A4
Authority
EP
European Patent Office
Prior art keywords
methods
therapeutic delivery
delivery platforms
generating therapeutic
generating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19875362.6A
Other languages
German (de)
English (en)
Other versions
EP3866981A1 (fr
Inventor
Mei He
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kansas
Kansas State University
Original Assignee
University of Kansas
Kansas State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kansas, Kansas State University filed Critical University of Kansas
Publication of EP3866981A1 publication Critical patent/EP3866981A1/fr
Publication of EP3866981A4 publication Critical patent/EP3866981A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00Magnetic separation
    • B03C1/02Magnetic separation acting directly on the substance being separated
    • B03C1/30Combinations with other devices, not otherwise provided for
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00Magnetic separation
    • B03C1/02Magnetic separation acting directly on the substance being separated
    • B03C1/28Magnetic plugs and dipsticks
    • B03C1/288Magnetic plugs and dipsticks disposed at the outer circumference of a recipient
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00Magnetic separation
    • B03C1/005Pretreatment specially adapted for magnetic separation
    • B03C1/01Pretreatment specially adapted for magnetic separation by addition of magnetic adjuvants
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00Magnetic separation
    • B03C1/02Magnetic separation acting directly on the substance being separated
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • G01N33/54333Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C2201/00Details of magnetic or electrostatic separation
    • B03C2201/18Magnetic separation whereby the particles are suspended in a liquid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C2201/00Details of magnetic or electrostatic separation
    • B03C2201/26Details of magnetic or electrostatic separation for use in medical or biological applications
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/491Blood by separating the blood components
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/4915Blood using flow cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
EP19875362.6A 2018-10-21 2019-10-21 Procédés de génération de plates-formes d'administration thérapeutique Withdrawn EP3866981A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862748470P 2018-10-21 2018-10-21
PCT/US2019/057237 WO2020086471A1 (fr) 2018-10-21 2019-10-21 Procédés de génération de plates-formes d'administration thérapeutique

Publications (2)

Publication Number Publication Date
EP3866981A1 EP3866981A1 (fr) 2021-08-25
EP3866981A4 true EP3866981A4 (fr) 2022-09-07

Family

ID=70331909

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19875362.6A Withdrawn EP3866981A4 (fr) 2018-10-21 2019-10-21 Procédés de génération de plates-formes d'administration thérapeutique

Country Status (9)

Country Link
EP (1) EP3866981A4 (fr)
JP (1) JP2022512762A (fr)
KR (1) KR20210088594A (fr)
CN (1) CN113195103A (fr)
AU (1) AU2019368213A1 (fr)
BR (1) BR112021007508A2 (fr)
CA (1) CA3117030A1 (fr)
IL (1) IL282538A (fr)
WO (1) WO2020086471A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11162143B2 (en) 2018-10-21 2021-11-02 The University Of Kansas Methods for generating therapeutic delivery platforms
WO2021226589A1 (fr) * 2020-05-08 2021-11-11 The University Of Kansas Compositions immunomagnétiques pour la capture spécifique au ph de vésicules extracellulaires
CN113005021B (zh) * 2020-06-17 2023-12-08 山东大学 一种用于外泌体裂解和检测的微流控芯片及方法
US20230390773A1 (en) * 2020-10-05 2023-12-07 Clara Biotech, Inc. Apparatus, system, and method for analyte release
KR20230026261A (ko) 2021-08-17 2023-02-24 한국과학기술원 면역 유도용 다층 소포체, 이를 포함하는 면역 유도용 약학 조성물 및 면역 유도용 다층 소포체의 제조방법
CN116819058A (zh) * 2023-05-18 2023-09-29 国科温州研究院(温州生物材料与工程研究所) 一种分析流体样本细胞外囊泡聚糖的方法及其装置和应用
WO2025118073A1 (fr) * 2023-12-04 2025-06-12 Rocket Science Health Corp. Formulations magnétiques pour l'échantillonnage de biomarqueurs et l'administration améliorée de médicaments

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993740A (en) * 1995-01-20 1999-11-30 Hitachi, Ltd. Immunoassay method and analyzer using magnetic particles
GB2383329A (en) * 2000-08-18 2003-06-25 Sense Proteomic Ltd Lipo-or amphiphilic scintillators and their use in assays
GB0318096D0 (en) * 2003-08-01 2003-09-03 Queen Mary & Westfield College Vaccine
AU2007353319A1 (en) * 2006-11-15 2008-11-20 Invitrogen Dynal As Methods for reversibly binding a biotin compound to a support
US20080302732A1 (en) * 2007-05-24 2008-12-11 Hyongsok Soh Integrated fluidics devices with magnetic sorting
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
KR20110111449A (ko) * 2008-12-31 2011-10-11 인터젠엑스 인크. 미세유체 칩을 갖는 기구
KR20120081972A (ko) * 2009-07-02 2012-07-20 아이티에이치 임뮨 세라피 홀딩스 에이비 엑소좀에 기초한 암의 치료
EP2726870B1 (fr) * 2011-06-29 2018-10-03 Academia Sinica Capture, purification et libération d'une substance biologique utilisant un revêtement de surface
CN103278628A (zh) * 2013-06-12 2013-09-04 齐齐哈尔医学院 一种幽门螺杆菌elisa检测与分离的方法和装置
US20150111777A1 (en) * 2013-09-24 2015-04-23 Kansas City University Of Medicine And Biosciences Biomarker for early neurodegeneration detection
WO2015139019A1 (fr) * 2014-03-14 2015-09-17 Mei He Surveillance non invasive du cancer utilisant un profilage microfluidique intégré de microvésicules circulantes
US10350599B2 (en) * 2014-03-14 2019-07-16 University Of Kansas Non-invasive monitoring cancer using integrated microfluidic profiling of circulating microvesicles
US10788486B2 (en) * 2016-10-09 2020-09-29 The University Of Kansas Graphene oxide-based nanolab and methods of detecting of exosomes
CN107764804B (zh) * 2017-10-09 2020-02-07 郑州大学 一种自组装聚hrp探针、制备方法、试剂盒及其应用
CN107723338B (zh) * 2017-10-27 2020-03-27 山东师范大学 一种在单分子水平同时检测多种dna糖基化酶的荧光化学传感器及其检测方法和应用

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GISS D ET AL: "MICROFLUIDICS TO ISOLATE UNTAGGED PROTEINS FROM CELL EXTRACTS FOF VISUAL ANALYSIS BY ELECTRON MICROSCOPY", 17TH MICROAFFINITY PURIFICATION OF PROTEINS BASED ON PHOTOLYTIC ELUTION: TOWARD AN EFFICIENT MICROBEAD AFFINITY CHROMATOGRAPHY ON A CHIP ELECTROPHORESIS 27-31 OCTOBER 2013, FREIBURG, GERMANY, 31 October 2013 (2013-10-31), pages 1785 - 1787, XP055947895, Retrieved from the Internet <URL:https://www.rsc.org/images/loc/2013/PDFs/Papers/597_0776.pdf> *
MIN-SOO KIM ET AL: "Study on bead-based micro biochip and analytical system for protein detection", TRANSDUCERS, SOLID-STATE SENSORS, ACTUATORS AND MICROSYSTEMS, 12TH INN ATIONAL CONFERENCE ON, 2003, PISCATAWAY, NJ, USA,IEEE, 8 June 2003 (2003-06-08), pages 1267, XP032377732, ISBN: 978-0-7803-7731-8, DOI: 10.1109/SENSOR.2003.1217003 *
QINGFU ZHU ET AL: "Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics", LAB ON A CHIP, vol. 18, no. 12, 1 January 2018 (2018-01-01), UK, pages 1690 - 1703, XP055709479, ISSN: 1473-0197, DOI: 10.1039/C8LC00246K *
See also references of WO2020086471A1 *
Z. ZHAO, J. SIBBITT; M. HE: "On-Chip Harvesting and Photo-Release of Immunogenic Extracellular Vesicles for Cancer Immunotherapy", MICROTAS 2017; 21ST INTERNATIONAL CONFERENCE ON MINIATURIZED SYSTEMS FOR CHEMISTRY AND LIFE SCIENCES (MICROTAS 2017), SAVANNAH, GEORGIA, USA, 22-26 OCTOBER 2017, vol. 2, 22 October 2017 (2017-10-22) - 26 October 2017 (2017-10-26), pages 898 - 899, XP009537868, ISBN: 978-1-7138-0272-3, Retrieved from the Internet <URL:https://www.proceedings.com/52575.html> *
ZHENG ZHAO ET AL: "Microfluidic on-demand engineering of exosomes towards cancer immunotherapy", LAB ON A CHIP, vol. 19, no. 10, 1 January 2019 (2019-01-01), UK, pages 1877 - 1886, XP055754271, ISSN: 1473-0197, DOI: 10.1039/C8LC01279B *

Also Published As

Publication number Publication date
CN113195103A (zh) 2021-07-30
WO2020086471A1 (fr) 2020-04-30
AU2019368213A1 (en) 2021-06-03
JP2022512762A (ja) 2022-02-07
EP3866981A1 (fr) 2021-08-25
KR20210088594A (ko) 2021-07-14
BR112021007508A2 (pt) 2021-08-10
IL282538A (en) 2021-06-30
CA3117030A1 (fr) 2020-04-30

Similar Documents

Publication Publication Date Title
EP3866981A4 (fr) Procédés de génération de plates-formes d&#39;administration thérapeutique
EP3380043A4 (fr) Appareil de pose contrôlée de valve cardiaque
EP3253382A4 (fr) Compositions pharmaceutiques pour thérapie combinée
EP4125973A4 (fr) Vaccinothérapie avec des néo-antigènes
EP4125815A4 (fr) Compositions thérapeutiques
EP3761991A4 (fr) Polythérapie pour maladies cardiovasculaires
EP3883934A4 (fr) Dendrimère thérapeutique
EP3823961A4 (fr) Dendrimère thérapeutique
IL292502A (en) Therapeutic methods using vadadustat
EP3773730A4 (fr) Formulations d&#39;administration de médicament
EP3291818A4 (fr) Compositions et procédés pour l&#39;administration d&#39;agents thérapeutiques dans le côlon
EP4028321A4 (fr) Élévation de plate-forme d&#39;élévateur de bateau
EP3655106A4 (fr) Polythérapie
GB201909493D0 (en) Therapeutic interactions
HK40079615A (en) Therapeutic methods using vadadustat
HK1254687A1 (zh) 用於癌症的联合疗法
AU2018904367A0 (en) Anthosa Delivery Platform
HK40048581A (en) Therapeutic methods
HK40087816A (en) Neoantigen vaccine therapy
HK40052985A (en) Anellosomes for delivering intracellular therapeutic modalities
HK40046768A (zh) 组合疗法
HK40061251A (en) Pharmaceutical methods
HK40060353A (en) Methods for administering corticosteroids
HK40072816A (en) Combination therapy
HK40052041A (zh) 新疗法

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210519

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220810

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/00 20060101ALI20220804BHEP

Ipc: G01N 33/48 20060101ALI20220804BHEP

Ipc: B03C 1/02 20060101ALI20220804BHEP

Ipc: B03C 1/30 20060101AFI20220804BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230726

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20240206